Bioventus
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bioventus generated cash of $15,344,000, which is more than the previous year. Cash used in financing activities reached the amount of -$26,653,000 last year. Net change in cash is therefore $5,127,000.
Cash Flow
| 2013 | 2.74M | -10.99M | 6.80M |
|---|---|---|---|
| 2014 | 15.10M | -31.37M | -6.64M |
| 2015 | 18.92M | -60.18M | 31.24M |
| 2018 | 45.18M | -6.10M | -13.25M |
| 2019 | 40.71M | -7.91M | -10.95M |
| 2020 | 71.79M | -20.5M | -29.56M |
| 2021 | 22.99M | -283.76M | 273.37M |
| 2022 | -13.53M | -116.43M | 62.07M |
| 2023 | 15.34M | 15.80M | -26.65M |
BVS Cash Flow Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 31.83M | 99.21M | 86.83M | 64.52M | 42.77M | 17.10M | 15.77M | 40.11M | 42.07M |
Operating activities | |||||||||
Net income | -96.73M | -213.39M | 9.58M | 14.72M | 8.11M | 4.44M | -34.11M | -12.9M | -22.36M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 57.36M | 66.80M | 34.87M | 28.64M | 30.31M | 29.23M | 33.07M | 28.82M | 24.45M |
Stock-based compensation expense | 2.72M | 17.58M | 19.84M | 10.10M | 10.84M | 0 | 3.32M | 2.35M | 5.68M |
| Deferred income tax benefit | 2.72M | 17.58M | 19.84M | 10.10M | 10.84M | 0 | 3.32M | 2.35M | 5.68M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 10.05M | -18.02M | -20.05M | -3.94M | -14.90M | -12.13M | -11.26M | -217K | -11.09M |
Inventories | 0 | -18.61M | 3.18M | -528K | -1.42M | 3.25M | -5.72M | 10.64M | -3.71M |
Accounts payable | 0 | 10.91K | 18.21M | 20.51M | 6.64M | 12.14M | 5.18M | 3.04M | -2.92M |
Cash generated by operating activities | 15.34M | -13.53M | 22.99M | 71.79M | 40.71M | 45.18M | 18.92M | 15.10M | 2.74M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | -13.52M | 0 | 0 | 0 | -941K | 0 | 0 |
Investments In Property Plant And Equipment | -7.36M | -11.52M | -7.37M | -20.67M | -8.34M | -6.06M | -7.44M | -20.83M | -6.35M |
Acquisitions Net | 34.67M | -104.84M | -262.87M | 0 | 430K | 0 | -51.45M | -10.54M | 0 |
Cash generated by investing activities | 15.80M | -116.43M | -283.76M | -20.5M | -7.91M | -6.10M | -60.18M | -31.37M | -10.99M |
Financing activities | |||||||||
Common Stock Issued | 778K | 5.82M | 107.57M | 0 | 0 | 0 | 50M | 0 | 0 |
Payments for dividends | 0 | 0 | -367K | -19.88M | -9.13M | 0 | -1.01M | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -23.26M | 59.62M | -166.20M | -59M | -1.36M | -5.25M | -17.73M | -177.08M | -3.53M |
Cash used in financing activities | -26.65M | 62.07M | 273.37M | -29.56M | -10.95M | -13.25M | 31.24M | -6.64M | 6.80M |
Net Change In Cash | 5.12M | -67.37M | 12.37M | 22.31M | 21.74M | 25.67M | -10.82M | -24.34M | -1.96M |
Cash at end of period | 36.96M | 31.83M | 99.21M | 86.83M | 64.52M | 42.77M | 4.95M | 15.77M | 40.11M |
| Data source | Data source | Data source | Data source |